Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report

Yuji Kitaichi,1 Takeshi Inoue,1 Nobuyuki Mitsui,1 Shin Nakagawa,1 Rie Kameyama,1 Yoshiyuki Hayashishita,1 Tohru Shiga,2 Ichiro Kusumi,1 Tsukasa Koyama1 1Department of Psychiatry, Graduate School of Medicine, Hokkaido University, Sapporo, Japan; 2Department of Nuclear Medicine, Graduate School of Med...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kitaichi Y, Inoue T, Mitsui N, Nakagawa S, Kameyama R, Hayashishita Y, Shiga T, Kusumi I, Koyama T
Format: article
Langue:EN
Publié: Dove Medical Press 2013
Sujets:
Accès en ligne:https://doaj.org/article/fd61bbf02b9a4995b8c48db7ac1b955d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!